Rewiring Lung Cancer Immunotherapy: The PD-L1–EphA2 Axis in CAR-T Evolution
International Journal of Contemporary Pathology · 26.06.2026 · 12 (1) · 31-34
DOI: 10.37506/3ph2sf03 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Contemporary Pathology, online erschienen am 26.06.2026. Verfasst von Birupaksha Biswas. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Non-small cell lung carcinoma remains difficult to treat despite advances in immunotherapy targeting thePD-1/PD-L1 axis, with limited durability of response. Chimeric antigen receptor T cell therapy has emerged as a novel strategy, particularly with targets such as EphA2 and PD-L1. This commentary highlights the shift of CAR-T therapy from direct tumor cytotoxicity toward modulation of the tumor microenvironment.EphA2 directed CAR-T cells demonstrate strong preclinical efficacy but are limited by antigen heterogeneity and potential off target effects. In contrast, PD-L1 targeted CAR-T cells provide dual activity by eliminating tumor cells and disrupting immunosuppressive signaling. Advances such as multi antigen targeting and cytokine engineered CAR-T cells further address resistance mechanisms.Early clinical evidence supports feasibility, though challenges in persistence and safety remain. The integration of tumor targeting with microenvironmental reprogramming represents a critical evolution in CAR-T design. Future strategies must focus on enhancing durability and safety to improve outcomes in lung carcinoma.
Zitieren
APA
Biswas, B. (2026). Rewiring Lung Cancer Immunotherapy: The PD-L1–EphA2 Axis in CAR-T Evolution. International Journal of Contemporary Pathology, 12(1), 31-34. https://doi.org/10.37506/3ph2sf03
Vancouver
Biswas B. Rewiring Lung Cancer Immunotherapy: The PD-L1–EphA2 Axis in CAR-T Evolution. International Journal of Contemporary Pathology. 2026;12(1):31-34. doi:10.37506/3ph2sf03
BibTeX
@article{Biswas2026,
author = {Biswas, Birupaksha},
title = {Rewiring Lung Cancer Immunotherapy: The PD-L1–EphA2 Axis in CAR-T Evolution},
journal = {International Journal of Contemporary Pathology},
year = {2026},
volume = {12},
number = {1},
pages = {31--34},
doi = {10.37506/3ph2sf03}
}
EUVIMED